Literature DB >> 1567468

Acid reaction products of indole-3-carbinol and their effects on cytochrome P450 and phase II enzymes in rat and monkey hepatocytes.

H M Wortelboer1, C A de Kruif, A A van Iersel, H E Falke, J Noordhoek, B J Blaauboer.   

Abstract

The effects of three acid condensation products of indole-3-carbinol (I3C), i.e. 3,3'-diindolylmethane (DIM), 5,6,11,12,17,18-hexahydrocyclonona[1,2-b:4,5-b':7,8-b"]tri-indole (CTI) and 2,3-bis[3-indolylmethyl]indole (BII), on cytochrome P450 and phase II enzymes were studied in primary cultures of rat and cynomolgus monkey liver cells. In rat hepatocytes all three indole derivatives dose-relatedly induced the ethoxyresorufin O-dealkylation (EROD) activity (to 24-fold) and 7 alpha-hydroxylation of testosterone (to 4-fold), whereas all three decreased the 16 alpha- and 2 alpha-testosterone hydroxylation (DIM to 60%, CTI and BII to a mere 5% of the control cells). Treatment of monkey hepatocytes with DIM and BII enhanced the EROD activity to 6- and 9-fold, respectively. Furthermore, BII decreased the 6 beta-hydroxylation of testosterone (to 60% of the untreated cultures) in monkey cells. Phase II enzymes were also affected. In rat hepatocytes DIM, CTI and BII enhanced DT-diaphorase (DTD) (= NAD(P)H-quinone reductase) activity, and DIM and BII the glucuronidation of 1-naphthol. In monkey cells BII only enhanced DTD, and no changes were observed in the glucuronidation of 1-naphthol after treatment with either DIM or BII. The indole derivatives did not affect glutathione S-transferase activity and sulfation of 1-naphthol in either rat or monkey hepatocytes. These results identify two novel acid condensation products of I3C, CTI and BII, as potent compounds in affecting biotransformation in rat as well as in monkey hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567468     DOI: 10.1016/0006-2952(92)90200-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.

Authors:  Laura M Beaver; Tian-Wei Yu; Elizabeth I Sokolowski; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-16       Impact factor: 4.219

Review 2.  Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Authors:  Sanjeev Banerjee; Dejuan Kong; Zhiwei Wang; Bin Bao; Gilda G Hillman; Fazlul H Sarkar
Journal:  Mutat Res       Date:  2011-06-15       Impact factor: 2.433

3.  Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed mice.

Authors:  A Joseph Bloom; Pramod Upadhyaya; Evan D Kharasch
Journal:  Biopharm Drug Dispos       Date:  2019-05-20       Impact factor: 1.627

Review 4.  Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.

Authors:  Stephen Safe; Sabitha Papineni; Sudhakar Chintharlapalli
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

5.  3,3'-diindolylmethane reduces levels of HIF-1alpha and HIF-1 activity in hypoxic cultured human cancer cells.

Authors:  Jacques E Riby; Gary L Firestone; Leonard F Bjeldanes
Journal:  Biochem Pharmacol       Date:  2008-02-07       Impact factor: 5.858

6.  Post-ingestion conversion of dietary indoles into anticancer agents.

Authors:  Li Ping Lin; Dan Liu; Jia Cheng Qian; Liang Wu; Quan Zhao; Ren Xiang Tan
Journal:  Natl Sci Rev       Date:  2021-08-13       Impact factor: 23.178

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.